CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
REVENUES:
Revenues	$ 154,079,692	$ 80,942,625
Cost of product revenue	118,814,535	79,769,341
Gross profit	35,265,157	1,173,284
OPERATING EXPENSES:
Research and development	3,613,764	3,646,060
Plasma center operating expenses	17,843,096	12,288,723
Amortization of intangible assets	715,353	715,353
Selling, general and administrative	52,458,024	42,896,889
Total operating expenses	74,630,237	59,547,025
LOSS FROM OPERATIONS	(39,365,080)	(58,373,741)
OTHER INCOME (EXPENSE):
Interest income	44,833	34,532
Interest expense	(19,279,373)	(13,056,834)
Loss on extinguishment of debt	(6,669,941)	0
Other expense	(634,389)	(251,575)
Other expense, net	(26,538,870)	(13,273,877)
NET LOSS	$ (65,903,950)	$ (71,647,618)
BASIC LOSS PER COMMON SHARE (in dollars per share)	$ (0.33)	$ (0.51)
DILUTED LOSS PER COMMON SHARE (in dollars per share)	$ (0.33)	$ (0.51)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	197,874,895	139,578,538
Diluted (in shares)	197,874,895	139,578,538
Product Revenue [Member]
REVENUES:
Revenues	$ 153,936,858	$ 80,799,791
License Revenue [Member]
REVENUES:
Revenues	$ 142,834	$ 142,834